BioInsights - Vaccine manufacturing: the future is global

Vaccine manufacturing: the future is global

Vaccine Insights 2022; 1(6), 293–298

DOI: 10.18609/vac.2022.041

Published: 28 November 2022
Interview
Matthew Downham

CEPI’s Matthew Downham discusses improving production efficiency with new platforms and tools, and how CEPI and its collaborators are working towards more geo-diversified vaccine manufacturing.

Matthew Downham is the Director, Manufacturing & Supply Chain Networks for Coalition for Epidemic Preparedness Innovations (CEPI). After a PhD in biochemical engineering at Birmingham University, UK, and a post-doctoral research fellowship in biomolecular sciences at Liverpool John Moores University, he joined the biopharmaceutical industry in 1997 and worked in vaccine R&D for companies including Novartis Vaccines & Diagnostics and AstraZeneca. He joined CEPI as the Sustainable Manufacturing Lead in 2021.

Charlotte Barker, Editor, BioInsights, speaks to Matthew Downham, Director, Manufacturing & Supply Chain Networks, CEPI